Le Lézard
Classified in: Health
Subjects: HEALTH, LIFESTYLE, TRADE SHOWS/SEMINARS/WEBINARS, MISCELLANEOUS, MISCELLANEOUS

Lift&Co. Expo 2021 Delivers Exciting, High-Energy Opening Day


Toronto, Ontario, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Lift&Co. Expo debuted a whiz-bang opening day at the Metro Toronto Convention Centre on November 18, 2021. After an anticipation-building hiatus, Canada's no. 1 cannabis conference and trade show did not disappoint on Day 1 of its triumphant return. In addition to an exceptional, forward-thinking conference, hundreds of attendees were treated to many of the signature surprises hinted in pre-show announcements.

Highlights included:

Missed Day 1? Never fear. There's plenty of excitement still to come!

Day 2 | Lift Psychedelics Business Summit
How can you not be curious? Feed that need with fascinating speakers from the world of today's modern psychedelics renaissance.

Day 2 | Lift&Co. Expo Industry Day
Trust us to serve up a day of totally-not-stuffy networking and learning opportunities exclusive to the cannabis and psychedelics industries.

Days 3 - 4 | Lift&Co. Expo Consumer Days
Two full days for recreational and medical consumers to connect with over 200+ cannabis and psychedelics exhibitors from Canada and around the world.

Lift&Co. Expo After Party
Saturday night's celebration will be presented by Hawthornetm at Toronto's iconic El Mocambo. The twist? Only those with a Golden Ticket may attend the After Party; Golden Tickets will be given away and raffled off on Friday and Saturday at Lift&Co. Expo by exhibitors, ambassadors, and event staff.

Tickets are on sale now for Lift&Co. Expo 2021.

A full agenda, speakers, and exhibitors can be found here.

ABOUT MCI

MCI is the global leader in engaging and activating audiences. Our business is founded on a simple human insight:?When people come together, magic happens. Since 1987, we have been bringing people together through?inspiring meetings, events, congresses and association or community management. MCI helps organizations harness the power of community by applying our strategic engagement and activation solutions to build unforgettable online and offline experiences that foster change, inspire, educate and enhance business performance. MCI is an independently owned company headquartered in Geneva, Switzerland, and boasts a global presence with 2,500+ professionals in 61?offices and 31 countries, who work with clients across Europe, the Americas, Asia-Pacific, India, and the Middle East.?Visit us at?http://www.mci-group.com?or?Twitter,?LinkedIn,?Facebook.

ABOUT MVP EDUCATION, LLC  

MVP Education, LLC is an equity investor who partners with associations, event owners and license owners to accelerate the growth, innovation, and impact of your events.



These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

18 mai 2024
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: